Safety and Efficacy of the Subcutaneous Implantable Defibrillator

Content Provider	Scilit
Author	Lewis, Geoffrey F. Gold, Michael R.
Copyright Year	2016
Description	Journal: Journal of the American College of Cardiology Multiple randomized, multicenter trials have established the role of the implantable cardioverter-defibrillator (ICD) in the treatment and prevention of sudden cardiac death. However, transvenous ICD leads have significant short- and long-term complications, offsetting some of the benefit of this therapy. This has led to the development of the entirely subcutaneous ICD. This system is safe and effective, avoiding the need for intravascular leads. It is best suited for patients at low risk for pacing and increased risk for transvenous lead complications. Ongoing randomized and long-term registries will help identify the optimal role of this device in clinical practice.
Related Links	https://core.ac.uk/download/pdf/81165754.pdf
Ending Page	454
Page Count	10
Starting Page	445
ISSN	07351097
DOI	10.1016/j.jacc.2015.11.026
Journal	Journal of the American College of Cardiology
Issue Number	4
Volume Number	67
Language	English
Publisher	Elsevier BV
Publisher Date	2016-02-01
Access Restriction	Open
Subject Keyword	Journal: Journal of the American College of Cardiology Cardiology and Cardiovascular Diseases Peripheral Vascular Disease Cardiac Arrhythmias Implantable Devices Sudden Cardiac Death Ventricular Fibrillation
Content Type	Text
Resource Type	Article
Subject	Cardiology and Cardiovascular Medicine